CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on November 18, 2016
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
November 18, 2016
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Scot Foley
| Re: | Cellectar Biosciences, Inc. | |
| Registration Statement on Form S-1 | ||
| File No. 333-214198 |
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-214198), as amended, be accelerated so that the Registration Statement will become effective at 4:20 p.m. on November 21, 2016, or as soon as practicable thereafter.
| Very truly yours, | |||
| CELLECTAR BIOSCIENCES, INC. | |||
| By: | /s/ James Caruso | ||
| James Caruso, President and Chief Executive Officer |
|||